GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Cyclically Adjusted PS Ratio

Orthofix Medical (Orthofix Medical) Cyclically Adjusted PS Ratio : 0.49 (As of Apr. 28, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Orthofix Medical Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Orthofix Medical's current share price is $12.99. Orthofix Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $26.70. Orthofix Medical's Cyclically Adjusted PS Ratio for today is 0.49.

The historical rank and industry rank for Orthofix Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

OFIX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.37   Med: 1.36   Max: 2.53
Current: 0.49

During the past years, Orthofix Medical's highest Cyclically Adjusted PS Ratio was 2.53. The lowest was 0.37. And the median was 1.36.

OFIX's Cyclically Adjusted PS Ratio is ranked better than
85.59% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs OFIX: 0.49

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Orthofix Medical's adjusted revenue per share data for the three months ended in Dec. 2023 was $5.394. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $26.70 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Orthofix Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Orthofix Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Cyclically Adjusted PS Ratio Chart

Orthofix Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.84 1.75 1.22 0.77 0.50

Orthofix Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.62 0.67 0.48 0.50

Competitive Comparison of Orthofix Medical's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Orthofix Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Cyclically Adjusted PS Ratio falls into.



Orthofix Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Orthofix Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=12.99/26.7
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orthofix Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Orthofix Medical's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.394/129.4194*129.4194
=5.394

Current CPI (Dec. 2023) = 129.4194.

Orthofix Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 5.496 99.695 7.135
201406 5.423 100.560 6.979
201409 5.380 100.428 6.933
201412 5.388 99.070 7.039
201503 4.792 99.621 6.225
201506 5.316 100.684 6.833
201509 5.364 100.392 6.915
201512 5.558 99.792 7.208
201603 5.260 100.470 6.776
201606 5.735 101.688 7.299
201609 5.358 101.861 6.808
201612 5.982 101.863 7.600
201703 5.714 102.862 7.189
201706 5.939 103.349 7.437
201709 5.667 104.136 7.043
201712 6.214 104.011 7.732
201803 5.759 105.290 7.079
201806 5.922 106.317 7.209
201809 6.018 106.507 7.313
201812 6.354 105.998 7.758
201903 5.686 107.251 6.861
201906 6.151 108.070 7.366
201909 5.987 108.329 7.153
201912 6.371 108.420 7.605
202003 5.431 108.902 6.454
202006 3.806 108.767 4.529
202009 5.721 109.815 6.742
202012 5.998 109.897 7.064
202103 5.408 111.754 6.263
202106 6.089 114.631 6.875
202109 5.687 115.734 6.359
202112 6.297 117.630 6.928
202203 5.348 121.301 5.706
202206 5.870 125.017 6.077
202209 5.674 125.227 5.864
202212 6.053 125.222 6.256
202303 4.903 127.348 4.983
202306 5.087 128.729 5.114
202309 4.940 129.860 4.923
202312 5.394 129.419 5.394

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Orthofix Medical  (NAS:OFIX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Orthofix Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Orthofix Medical (Orthofix Medical) Business Description

Traded in Other Exchanges
Address
3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Executives
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha officer: CECO & Interim CLO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie officer: VP, Controller, Interim CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny officer: President of Global Spine C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic officer: CFO C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine director, officer: President & CEO 7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran officer: Chief Legal Officer 6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West director C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci director 7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik director
Rice Doug officer: CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting officer: Chief Legal Officer 3451 PLANO PARKWAY, LEWISVILLE TX 75056